Chemoinformaics analysis of 5-O-METHYLGENISTEIN
| Molecular Weight | 284.267 | nRot | 2 |
| Heavy Atom Molecular Weight | 272.171 | nRig | 18 |
| Exact Molecular Weight | 284.068 | nRing | 3 |
| Solubility: LogS | -3.407 | nHRing | 1 |
| Solubility: LogP | 2.716 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 38.7315 |
| nHD | 2 | BPOL | 16.3785 |
| QED | 0.756 |
| Synth | 2.277 |
| Natural Product Likeliness | 1.286 |
| NR-PPAR-gamma | 0.767 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.991 |
| HIA | 0.005 |
| CACO-2 | -4.657 |
| MDCK | 0.0000123 |
| BBB | 0.026 |
| PPB | 0.952277 |
| VDSS | 0.536 |
| FU | 0.0339477 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.728 |
| CYP2c19-inh | 0.855 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.664 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.9 |
| CYP2d6-sub | 0.891 |
| CYP3a4-inh | 0.846 |
| CYP3a4-sub | 0.145 |
| CL | 7.806 |
| T12 | 0.869 |
| hERG | 0.043 |
| Ames | 0.097 |
| ROA | 0.238 |
| SkinSen | 0.775 |
| Carcinogencity | 0.28 |
| EI | 0.96 |
| Respiratory | 0.108 |
| NR-Aromatase | 0.69 |
| Antiviral | Yes |
| Prediction | 0.799242 |